• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Header Right

Search

  • Home
  • Expertise
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Executive Team
      • Study Management
    • History
    • Careers
    • Privacy policy / GDPR
  • Contact

Do Minh Thai

Director, Statistics and Methodology

Do Minh Thai brings four decades of experience in biostatistics to his role as Director of Statistics and Methodology. Influential since the inception of ZEG Berlin, he has comprehensive knowledge in the analysis of clinical and epidemiological studies with particular expertise in the management of large databases.  He coordinates the complex statistical analysis on multiple ZEG Berlin projects.

Thai studied mathematics at the University of Greifswald (Germany), receiving his PhD in Mathematical Cybernetics and Computer Sciences in 1977.  Throughout his career Thai has established himself as a reputable partner delivering exacting study design, data management and data analysis.

 

Publications

Reed Suzanne, Do Minh Thai, Lange Jens, Koro Carol, Fox Michelle, Heinemann Klaas, Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA) Contraception. 2019; pii: S0010-7824(19)30131-3. 10.1016/j.contraception.2019.03.052.
Barnett Clare, Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study Contraception & Reproductive Health Care. 2019; 1-4. 10.1080/13625187.2019.1629412.
Barnett Clare, Möhner Sabine, Do Minh Thai, Heinemann Klaas, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study The European Journal of Contraception and Reproductive Health Care. 2018; page 1-5.
Heinemann Klaas, Barnett Clare, Reed Suzanne, Möhner Sabine, Do Minh Thai, IUD use among parous women and risk of uterine perforation: a secondary analysis Contraception. 2017; Volume 95, Issue 6, Pages 605–607.
Bauerfeind Anja, Möhner Sabine, Do Minh Thai, Heinemann Klaas, The Influence of Women’s Educational Level on Unintended Pregnancy Rates amongst Users of Combined Oral Contraceptives Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
Heinemann Klaas, Dinger Jürgen, Do Minh Thai, Franke Christian, Unintended Pregnancies in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
Heinemann Klaas, Dinger Jürgen, Do Minh Thai, Franke Christian, Cardiovascular Safety in Users of Different Combined Oral Contraceptives – Final results from the INAS-SCORE Study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.
Barnett Clare, Bauerfeind Anja, Do Minh Thai, Heinemann Klaas, Influence of age and BMI on risk of venous thromboembolism: a meta-analysis of 246,513 women using combined oral contraceptives based on 521,516 women-years. Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Bauerfeind Anja, Barnett Clare, Do Minh Thai, Heinemann Klaas, The effect of BMI on unintended pregnancy rates amongst users of combined oral contraceptives Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Heinemann Klaas, Möhner Sabine, Reed Suzanne, Do Minh Thai, Unwanted pregnancies in women using Intrauterine Devices: final results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Heinemann Klaas, Möhner Sabine, Do Minh Thai, Reed Suzanne, Intrauterine Devices and the Risk of Uterine Perforations: Final Results from the EURAS-IUD 5-years study Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070.
Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Impact of Estrogen Type on Cardiovascular Safety of Combined Oral Contraceptives Contraception. 2016; Oct;94(4):328-39. 10.1016/j.contraception.2016.06.010.
Heinemann Klaas, Reed Suzanne, Möhner Sabine, Do Minh Thai, Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception. 2015; Apr;91(4):280-3. 10.1016/j.contraception.2015.01.011.
Bardenheuer Kristina, Heinemann Klaas, Do Minh Thai, Franke Christian, Cardiovascular Safety in Users of Different Combined Oral Contraceptives - Final Results from the INAS-SCORE study Pharmac. 2015; (24) S1, 1–587. 10.1002/pds.3838.
Heinemann Klaas, Reed Suzanne, Möhner Sabine, Do Minh Thai, Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception. 2015; 10.1016/j.contraception.2015.01.007.
Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Venous thromboemolism in users of a 24-day regimen of a combined oral contraceptive compare to conventional 21-day regimens: final results from the INAS-OC study. Pharmacoepidemiology and Drug Safety. 2013; 22(S1) 1-521. 10.1002/pds.3512.
Heinemann Lothar A , Do Minh Thai, Heinemann Klaas, Lindemann M , Filonenko A, Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities. Health Care Women International. 2012; Feb;33(2):109-24.
Dinger Jürgen, Bardenheuer Kristina, Do Minh Thai, Dose of estrogen and contraceptive failure rates of combined oral contraceptives. Pharmacoepidemiology and Drug Safety. 2011; Aug: 20(S1) 75.
Dinger Jürgen, Do Minh Thai, Bardenheuer Kristina, Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstetrics and Gynecology. 2011; 117:33-40.
Dinger Jürgen, Assmann Anita, Möhner Sabine, Do Minh Thai, Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care. 2010; 36(3):123-129.
Bardenheuer Kristina, Dinger Jürgen, Do Minh Thai, Franke Christian, Leddin Janko, Differences in drug utilization of oral contraceptives in the US and Europe. Pharmacoepidemiology and Drug Safety. 2010; 19:S241.
Dinger Jürgen, Do Minh Thai, Möhner Sabine, The risk of venous thromboembolism in OC users: time patterns after initiation of treatment. Pharmacoepidemiology and Drug Safety. 2010; 19:S214-215.
Dinger Jürgen, Möhner Sabine, Do Minh Thai, Early use effects on the risk of venous thromboembolism after initiation of oral contraceptive use. Eur J Contracept Reprod Health Care. 2010; 15;S1:43.
Heinemann Lothar A , Do Minh Thai, Filonenko A, Uhl-Hochgräber K, Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life. The Patient. Patient-Centered Outcomes Research. 2010; 3(2):113-123.
Heinemann Lothar A , Dinger Jürgen, Assmann Anita, Do Minh Thai, Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare" Contraception. 2010; May;81(5):401-7. 10.1016/j.contraception.2009.12.014.
Dinger Jürgen, Cronin Maureen, Möhner Sabine, Schellschmidt Ilka, Do Minh Thai, Westhoff C, Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2009; Sep;201(3):263.e1-9. doi: 10.1016/j.ajog.2009.03.017.
Assmann Anita, Dinger Jürgen, Filonenko A, Do Minh Thai, Heinemann Lothar A , Impact of severe premenstrual disorders on work, daily life, social relations, and quality of life: preliminary results of a multinational follow-up study. Pharmacoepidemiol Drug Saf. 2008; 17: S116.
Raff T, Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, The risk of uterine and ovarian cancer for different formulations of hormone therapy (HT). The Open Epidemiology Journal. 2008; 1:17-25.
Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.
Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.
Dinger Jürgen, Heinemann Lothar A , Möhner Sabine, Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Möhner Sabine, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.
Schellschmidt I, Do Minh Thai, Möhner Sabine, Dinger Jürgen, Factors influencing return to fertility after use of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S25.
Kratzik C, Heinemann Lothar A , Saad F, Do Minh Thai, Rücklinger E, Composite screener for androgen deficiency related to the Aging Males’ Symptoms scale. Aging Male. 2005; 8 (3/4):157-161.
Spannagl M, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study Thrombosis Journal . 2005; 3:8 (20 Jul 2005). DOI: 10.1186/1477-9560-3-8.
Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Hilpert J, Spannagl M, VTE risk assessment – a prognostic model: BATER cohort study of young women Thrombosis Journal. 2005; 2005;3:5 (18 April 2005). DOI: 10.1186/1477-9560-3-5.
Heinemann Lothar A , Saad F, Heinemann Klaas, Do Minh Thai, Can results of the AMS scale predict those of screening scales for androgen deficiency?. Aging Male. 2004; 7:211-18.
Moore C, Huebler D, Zimmermann T, Heinemann Lothar A , Saad F, Do Minh Thai, The AMS scale as outcome measure for treatment of androgen deficiency Eur Urology. 2004; 46:80-7.
Heinemann Klaas, Alexander Ruebig Alexander, Potthoff P, Schneider HPG, Strelow Frank, Heinemann Lothar A , Do Minh Thai, The Menopause Rating Scale: A methodological review. Health and Quality of Life Outcomes. 2004; 2:45 (2 September 2004). 10.1186/1477-7525-2-45.
Heinemann Lothar A , Do Minh Thai, Strelow Frank, Gerbsch Silvia, Schnitker Jörg, Schneider HPG, The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? Health and Quality of Life Outcome. 2004; 2:67. Doi:10.1186/1477-7525-2-67.
Daig I , Heinemann Lothar A , Kim S, Leungwattanakij S, Badia X, Myon E, Saad F, Potthoff P, Do Minh Thai, The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics Health and Quality of Life Outcomes. 2003; 1:77 (December 2003). 10.1186/1477-7525-1-77.
Heinemann Klaas, Heinemann Lothar A , Do Minh Thai, Möhner M, Heuchert G E, Occupational exposure and liver cancer in women: results of the Multicentre International Liver Tumour Study (MILTS). Occup Med (Lond). 2000; Aug;50(6):422-9.
Heinemann Lothar A , Thorogood M, Kerle K M, Assmann Anita, Do Minh Thai, Use of psychotropic drugs and risk of cardiovascular events. Life and Medical Science Online. 2000; 1.

sidebar

Executive Team

  • Klaas Heinemann
  • Christine Hagemann
  • Sabine Möhner
  • Clare Barnett
  • Alfred Pauls
  • Jürgen Dinger
  • Johanna Poppe

Study Management

  • Clare Barnett
  • Divine Akumo
  • Pauline De Corte
  • Christine Hagemann
  • Suzanne Reed
  • Janina Flume
  • Anja Bauerfeind
  • Do Minh Thai
  • Sabine Möhner
  • Karl Pauls
  • Klaas Heinemann

Who We Are

ZEG Berlin is a private research institute specialized in conducting post-authorization safety / efficacy studies using primary data collection methods. From protocol development to the final publication of study results, we believe in entering into a collaborative partnership with our clients, striving to develop study designs that are best equipped to deliver quality data that accurately answers the question at hand.

Our specialized team of highly-skilled physicians, epidemiologists and statisticians has extensive experience in the design of studies for complex epidemiological questions and is ready to assist you in developing studies that are best suited to your needs. We are a full-service institute, offering all components for post-authorization medical research – from study design to project implementation, study conduct and the publication and presentation of results.

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2021 ZEG Berlin

Impressum

Website by Laura Yeffeth

This site uses cookies: Find out more.